220 related articles for article (PubMed ID: 18332263)
1. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Cheung C; Marchant D; Walker EK; Luo Z; Zhang J; Yanagawa B; Rahmani M; Cox J; Overall C; Senior RM; Luo H; McManus BM
Circulation; 2008 Mar; 117(12):1574-82. PubMed ID: 18332263
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis.
Meng XH; Wang Y; Zhuang JX; Han XZ; Chen Y; Jin YP; Wang YL; Yu YH; Spires JP; Song GJ
Chin Med J (Engl); 2004 Aug; 117(8):1195-9. PubMed ID: 15361294
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
5. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
7. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
Shi Y; Chen C; Lisewski U; Wrackmeyer U; Radke M; Westermann D; Sauter M; Tschöpe C; Poller W; Klingel K; Gotthardt M
J Am Coll Cardiol; 2009 Apr; 53(14):1219-26. PubMed ID: 19341864
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
10. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
11. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
[TBL] [Abstract][Full Text] [Related]
12. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
13. Letter by Pinto and Heymans regarding article, "Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice".
Pinto YM; Heymans S
Circulation; 2008 Nov; 118(20):e697. PubMed ID: 19001029
[No Abstract] [Full Text] [Related]
14. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.
Rutschow S; Leschka S; Westermann D; Puhl K; Weitz A; Ladyszenskij L; Jaeger S; Zeichhardt H; Noutsias M; Schultheiss HP; Tschope C; Pauschinger M
Eur J Pharmacol; 2010 Mar; 630(1-3):145-51. PubMed ID: 20035743
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
[TBL] [Abstract][Full Text] [Related]
16. Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse.
Yun SH; Shin JO; Lim BK; Kim KL; Gil CO; Kim DK; Jeon ES
Virus Res; 2007 Jun; 126(1-2):62-8. PubMed ID: 17350707
[TBL] [Abstract][Full Text] [Related]
17. Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis.
Seizer P; Klingel K; Sauter M; Westermann D; Ochmann C; Schönberger T; Schleicher R; Stellos K; Schmidt EM; Borst O; Bigalke B; Kandolf R; Langer H; Gawaz M; May AE
J Mol Cell Cardiol; 2012 Jul; 53(1):6-14. PubMed ID: 22446162
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinase-9 in myocardium of mice with viral myocarditis].
Yang M; Chen CY; Cai ZL; Chen BL; Cheng L; Li H
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):669-73. PubMed ID: 21849121
[TBL] [Abstract][Full Text] [Related]
20. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
